Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $2.22 billion. The enterprise value is $1.79 billion.
| Market Cap | 2.22B |
| Enterprise Value | 1.79B |
Important Dates
The next confirmed earnings date is Friday, October 30, 2026, before market open.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 133.05 million shares outstanding. The number of shares has decreased by -3.83% in one year.
| Current Share Class | 133.05M |
| Shares Outstanding | 133.05M |
| Shares Change (YoY) | -3.83% |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | 2.19% |
| Owned by Institutions (%) | 64.72% |
| Float | 129.22M |
Valuation Ratios
The trailing PE ratio is 7.22 and the forward PE ratio is 20.16.
| PE Ratio | 7.22 |
| Forward PE | 20.16 |
| PS Ratio | 6.89 |
| Forward PS | 6.25 |
| PB Ratio | 3.39 |
| P/TBV Ratio | 3.39 |
| P/FCF Ratio | 12.51 |
| P/OCF Ratio | 12.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.64, with an EV/FCF ratio of 10.10.
| EV / Earnings | 5.69 |
| EV / Sales | 5.55 |
| EV / EBITDA | 9.64 |
| EV / EBIT | 10.76 |
| EV / FCF | 10.10 |
Financial Position
The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.09.
| Current Ratio | 6.12 |
| Quick Ratio | 5.57 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.31 |
| Debt / FCF | 0.33 |
| Interest Coverage | 42.87 |
Financial Efficiency
Return on equity (ROE) is 61.42% and return on invested capital (ROIC) is 71.38%.
| Return on Equity (ROE) | 61.42% |
| Return on Assets (ROA) | 15.34% |
| Return on Invested Capital (ROIC) | 71.38% |
| Return on Capital Employed (ROCE) | 22.76% |
| Weighted Average Cost of Capital (WACC) | 12.90% |
| Revenue Per Employee | $2.51M |
| Profits Per Employee | $2.46M |
| Employee Count | 128 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.12 |
Taxes
| Income Tax | -147.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.25% in the last 52 weeks. The beta is 1.61, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | +36.25% |
| 50-Day Moving Average | 16.49 |
| 200-Day Moving Average | 15.65 |
| Relative Strength Index (RSI) | 49.48 |
| Average Volume (20 Days) | 781,468 |
Short Selling Information
The latest short interest is 7.78 million, so 5.85% of the outstanding shares have been sold short.
| Short Interest | 7.78M |
| Short Previous Month | 7.92M |
| Short % of Shares Out | 5.85% |
| Short % of Float | 6.02% |
| Short Ratio (days to cover) | 9.71 |
Income Statement
In the last 12 months, AUPH had revenue of $321.74 million and earned $314.27 million in profits. Earnings per share was $2.31.
| Revenue | 321.74M |
| Gross Profit | 272.14M |
| Operating Income | 166.07M |
| Pretax Income | 167.12M |
| Net Income | 314.27M |
| EBITDA | 185.42M |
| EBIT | 166.07M |
| Earnings Per Share (EPS) | $2.31 |
Balance Sheet
The company has $486.88 million in cash and $58.66 million in debt, with a net cash position of $428.22 million or $3.22 per share.
| Cash & Cash Equivalents | 486.88M |
| Total Debt | 58.66M |
| Net Cash | 428.22M |
| Net Cash Per Share | $3.22 |
| Equity (Book Value) | 657.52M |
| Book Value Per Share | 4.91 |
| Working Capital | 491.88M |
Cash Flow
In the last 12 months, operating cash flow was $177.16 million and capital expenditures -$135,000, giving a free cash flow of $177.03 million.
| Operating Cash Flow | 177.16M |
| Capital Expenditures | -135,000 |
| Depreciation & Amortization | 19.36M |
| Net Borrowing | -18.09M |
| Free Cash Flow | 177.03M |
| FCF Per Share | $1.33 |
Margins
Gross margin is 84.58%, with operating and profit margins of 51.61% and 97.68%.
| Gross Margin | 84.58% |
| Operating Margin | 51.61% |
| Pretax Margin | 51.94% |
| Profit Margin | 97.68% |
| EBITDA Margin | 57.63% |
| EBIT Margin | 51.61% |
| FCF Margin | 55.02% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.83% |
| Shareholder Yield | 3.83% |
| Earnings Yield | 13.85% |
| FCF Yield | 7.99% |
Analyst Forecast
The average price target for AUPH is $18.00, which is 8.11% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.00 |
| Price Target Difference | 8.11% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 16.47% |
| EPS Growth Forecast (3Y) | -12.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 1:50.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |